Palisade Bio Inc (PALI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 0 | 250 | 0 | 0 | 0 |
| Gross Profit | N/A | 250 | N/A | N/A | N/A |
| Operating Expenses | 14,859 | 13,320 | 15,721 | 41,854 | 9,297 |
| Operating Income | -14,859 | -13,070 | -15,721 | -41,854 | -9,297 |
| Interest Expense | 12 | 15 | 13 | 2,398 | 235 |
| Other Income | 433 | 785 | 1,474 | 17,636 | -803 |
| Pre-tax Income | -14,438 | -12,300 | -14,260 | -26,616 | -10,335 |
| Net Income Continuous | -14,438 | -12,300 | -14,260 | -26,616 | -10,335 |
| Net Income | $-14,438 | $-12,300 | $-14,260 | $-26,616 | $-10,335 |
| EPS Basic Total Ops | -10.19 | -27.01 | -247.83 | -2,143.18 | -2,788.61 |
| EPS Basic Continuous Ops | -10.20 | -26.97 | -242.95 | -2,145.38 | -2,792.85 |
| EPS Diluted Total Ops | -10.19 | -27.01 | -247.83 | -2,544.83 | -2,788.61 |
| EPS Diluted Continuous Ops | -10.20 | -26.97 | -242.95 | -2,133.91 | -2,792.85 |
| EPS Diluted Before Non-Recurring Items | -10.19 | -26.99 | -247.83 | -3,245.88 | -5,261.32 |
| EBITDA(a) | $-14,856 | $-13,066 | $-15,718 | $-41,852 | $-9,294 |